Taribavirin
Taribavirin is an oral, liver-targeting inhibitor of inosine monophosphate dehydrogenase (IMPDH) developed for hepatitis C virus (HCV) research. Its design aims to minimize red blood cell distribution, thereby reducing the risk of hemolytic anemia in experimental models, making it a tool for studying antiviral mechanisms in vitro and in vivo.
Product Specifications
CAS Number
119567-79-2
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
O[C@H]1[C@@H] (O[C@H] (CO) [C@H]1O) N2N=C (C (=N) N) N=C2
Molecular Formula
C8H13N5O4
Molecular Weight
243.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB1025-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26 + 57), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSQ050046-01 10 µg
Recombinant Cynomolgus PD-L1/B7-H1/CD274 Protein (Fc Tag)
Sign In for Pricing
View Details PKSQ050046-02 50 µg
Recombinant Cynomolgus PD-L1/B7-H1/CD274 Protein (Fc Tag)
Sign In for Pricing
View Details 